Search

Austen Terwilliger (TAILΦR Initiative, Baylor College of Medicine) and colleagues have published a paper outlining the concept, structure, and process behind TAILΦR's method of addressing bacterial infections in vulnerable patients through

Armata Pharmaceuticals, a phage therapy biotech company in Los Angeles, is hiring for several positions.

We are urgently seeking Staphylococcus epidermidis phages for a patient in the USA. Ways to help at this stage: - By sending your phages for testing on the patient's strain - By receiving the strain and testing your phages - By helping sp

Vitalis Phage Therapy In case you missed it, Pranav Johri of Vitalis Phage Therapy interviewed Jean-Paul Pirnay of the Queen Astrid Military Hospital in Belgium today on All About Phage Therapy. Watch the recording here!

The Academy of Finland has granted 10 million Euro for research into COVID-related projects, and part of that will fund phage work! Researchers at the University of Jyväskylä and University of Helsinki in Finland were awarded funding for a

Hugo Oliveira (University of Minho, Portugal) and colleagues published a new paper in Applied and Environmental Microbiology showing that a phage tailspike with EPS-depolymerase activity, encoded by a phage belonging to a new genus within t

Josef Prazak (Bern University Hospital, Switzerland) and colleagues published a new paper in Critical Care Medicine showing that prophylactically administering nebulized phages to rats with experimental ventilator-associated pneumonia reduc

Bartłomiej Grygorcewicz (Pomeranian Medical University in Szczecin, Poland) and colleagues published a new paper in Microbial Drug Resistance showing that Acinetobacter baumannii phages could reduce biofilm biomass in a human urine model, a

Heather Hendrickson's lab at Massey University in New Zealand is working on finding phages for honeybee pathogens. Here's a nice video update from Heather, which also features Danielle Kok, a PhD student isolating the phages for this projec

TAILOR, a non-profit initiative in Houston, Texas that provides therapeutic phages as a service, has a new website! Read more about TAILOR here!

We are urgently seeking Staphylococcus epidermidis phages for a patient in the USA. Ways to help at this stage: - By sending your phages for testing on the patient's strain - By receiving the strain and testing your phages - By helping sp

Matthew Brown (Laboratory Corporation of America Holdings, North Carolina) and colleagues published a new paper in Viruses on the development and evaluation of a new phage-based MRSA diagnostic screen. The screen uses two luciferase reporte

Eric Sumrall (ETH Zurich) and colleagues published a new paper in Applied and Environmental Microbiology describing a novel phage protein tool kit that can be used for glycotyping and specific separation of Listeria monocytogenes

Mihnea Mangalea and Breck Duerkop (University of Colorado School of Medicine) published a new minireview in Infection and Immunity on the physiological consequences of different phage resistance mechanisms, and how this understanding can im

Peter Voorhees (University of North Carolina-Chapel Hill) and colleagues published a new review in the Journal of Controlled Release on the challenges and opportunities for phage-based in situ microbiome engineering in the gut.

Bacterial pathogens of fish cause major problems for fish farmers. Bernardo Veyrand‐Quirós (Instituto Politécnico Nacional, Mexico) and colleagues published a new paper in the Journal of Applied Microbiology showing that phage therapy incre

Lucy Furfaro (University of Western Australia) and colleagues published a new paper in PLOS ONE showing host range, morphological and genomic characterization of phages with activity against clinical Streptococcus agalactiae isolates from p

We are urgently seeking Citrobacter freundii phages (and phage manufacturing capacity) for a patient in the USA. Ways to help at this stage: - By preparing clinical-grade phage preparations for this patient (one phage already identified,

Armata Pharmaceuticals just received a $15 million award from the US Department of Defense to take its Staphylococcus aureus phage cocktail to phase 1b/2 clinical trials.

How should we optimally design phage cocktail timing and dosage to deal with evolutionary escape of pathogens? Guanlin Li and Chung Yin Leung (Georgia Institute of Technology) and colleagues published a new paper on using mathematical model